EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours

被引:44
作者
Gear, Jonathan [1 ,2 ]
Chiesa, Carlo [3 ]
Lassmann, Michael [4 ]
Gabina, Pablo Minguez [5 ]
Tran-Gia, Johannes [4 ]
Stokke, Caroline [6 ]
Flux, Glenn [1 ,2 ]
机构
[1] Royal Marsden Hosp, Joint Dept Phys, Sutton, Surrey, England
[2] Inst Canc Res, Sutton, Surrey, England
[3] Fdn IRCCS Ist Nazl Tumori, Nucl Med, Milan, Italy
[4] Univ Wurzburg, Dept Nucl Med, D-97080 Wurzburg, Germany
[5] Gurutzeta Cruces Univ Hosp, Dept Med Phys & Radiat Protect, Baracaldo, Spain
[6] Oslo Univ Hosp, Div Radiol & Nucl Med, Dept Diagnost Phys, Oslo, Norway
关键词
Dosimetry; Molecular radiotherapy; Iodine-131; mIBG; Neuroendocrine; Neuroblastoma; WHOLE-BODY DOSIMETRY; RADIONUCLIDE THERAPY; IODINE-131-METAIODOBENZYLGUANIDINE THERAPY; MONTE-CARLO; PHASE I/II; NEUROBLASTOMA; SPECT; I-131-METAIODOBENZYLGUANIDINE; METAIODOBENZYLGUANIDINE; DEADTIME;
D O I
10.1186/s40658-020-0282-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of the EANM Dosimetry Committee Series on "Standard Operational Procedures for Dosimetry" (SOP) is to provide advice to scientists and clinicians on how to perform patient-specific absorbed dose assessments. This SOP describes image and data acquisition parameters and dosimetry calculations to determine the absorbed doses delivered to whole-body, tumour and normal organs following a therapeutic administration of I-131 mIBG for the treatment of neuroblastoma or adult neuroendocrine tumours. Recommendations are based on evidence in recent literature where available and on expert opinion within the community. This SOP is intended to promote standardisation of practice within the community and as such is based on the facilities and expertise that should be available to any centre able to perform specialised treatments with radiopharmaceuticals and patient-specific dosimetry. A clinical example is given to demonstrate the application of the absorbed dose calculations.
引用
收藏
页数:21
相关论文
共 60 条
[1]  
ADAMS R, 1978, J NUCL MED, V19, P538
[2]   Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with 131I-Tositumomab Therapy [J].
Amro, Hanan ;
Wilderman, Scott J. ;
Dewaraja, Yuni K. ;
Roberson, Peter L. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) :654-659
[3]   Factors affecting the stability and repeatability of gamma camera calibration for quantitative imaging applications based on a retrospective review of clinical data [J].
Anizan, Nadge ;
Wang, Hao ;
Zhou, Xian C. ;
Hobbs, Robert F. ;
Wahl, Richard L. ;
Frey, Eric C. .
EJNMMI RESEARCH, 2014, 4 :1-11
[4]   Spatial aspects of combined modality radiotherapy [J].
Bodey, RK ;
Evans, PM ;
Flux, GD .
RADIOTHERAPY AND ONCOLOGY, 2005, 77 (03) :301-309
[5]   Dosimetry for fractionated 131I-mIBG therapies in patients with primary resistant high-risk neuroblastoma:: Preliminary results [J].
Buckley, Susan E. ;
Saran, Frank H. ;
Gaze, Mark N. ;
Chittenden, Sarah ;
Partridge, Mike ;
Lancaster, Donna ;
Pearson, Andrew ;
Flux, Glenn D. .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (01) :105-112
[6]   Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma [J].
Buckley, Susan E. ;
Chittenden, Sarah J. ;
Saran, Frank H. ;
Meller, Simon T. ;
Flux, Glenn D. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) :1518-1524
[7]  
Casey M., 2012, Nema Standards Publication nu 22012: Performance Measurements of Positron Emission Tomographs
[9]  
Chiesa C, 2013, Q J NUCL MED MOL IM, V57, P161
[10]   Optimization of equipment and methodology for whole-body activity retention measurements in children undergoing targeted radionuclide therapy [J].
Chittenden, Sarah J. ;
Pratt, Brenda E. ;
Pomeroy, Kay ;
Black, Peter ;
Long, Clive ;
Smith, Nicholas ;
Buckley, Susan E. ;
Saran, Frank H. ;
Flux, Glenn D. .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (02) :243-249